Dihydroboldenone Cypionate Injections (DHB / 1-Test Cyp)
Dihydroboldenone Cypionate—universally recognized in athletic performance communities as DHB or 1-Testosterone Cypionate—is a 5-alpha-reduced structural derivative of boldenone engineered to deliver remarkable muscular hardness, dense contractile mass, and prominent vascularity without estrogenic conversion. Bound to a long-acting cypionate ester, DHB provides sustained anabolic signaling with exceptional androgen receptor binding affinity, making it a premier tool for lean mass accumulation and competitive pre-contest preparation.
Our verified catalog features authentic pharmaceutical-grade dihydroboldenone cypionate solutions formulated in premium sterile carrier oils, ensuring accurate active compound concentration, optimum depot stability, and certified chemical purity.
Mechanism of Action & Pharmacological Profile
The pharmacodynamics of dihydroboldenone cypionate are defined by the reduction of the double bond between carbon positions 4 and 5 on the boldenone backbone, forming 1-dihydrotestosterone. Esterified with a cyclopentylpropionate chain at the 17-beta position, the molecule exhibits distinct biological characteristics:
- Total Immunity to Aromatization: Because of the 5-alpha-reduced A-ring configuration, DHB cannot interact with the aromatase enzyme complex, preventing any peripheral conversion into estradiol and eliminating subcutaneous fluid accumulation.
- High Anabolic Affinity: Demonstrates an anabolic receptor binding profile significantly stronger than native testosterone and boldenone, stimulating myofibrillar protein synthesis, cellular nitrogen retention, and muscular density.
- Zero Progestogenic Activity: Unlike 19-nor compounds (such as Nandrolone or Trenbolone), dihydroboldenone does not bind to progesterone receptors, completely eliminating prolactin-mediated side effects.
Technical Specifications & Administration Protocols
Injectable Dihydroboldenone Cypionate is formulated as a sterile oil preparation packaged in 10 ml multi-dose glass vials or single-dose glass ampoules. Due to its extended cypionate ester chain, weekly or split bi-weekly administrations sustain stable circulating plasma concentrations.
| Specification | Standard Lean Mass Protocol | Advanced Conditioning Regimen |
|---|---|---|
| Formulation Type | Sterile oil solution | Sterile oil solution |
| Administration Frequency | Split into 2 weekly injections | Injected every 3 days or 2x weekly |
| Protocol Duration | 10–12 weeks | 12–14 weeks |
| Primary Focus | Dense tissue accrual & strength | Vascularity, definition & contest prep |
| Active Half-Life | Approx. 7–8 days | Approx. 7–8 days |
Primary Applications in Training Protocols
- Dry Muscular Hypertrophy: Promotes solid, grain-like muscle tissue growth without the intracellular puffiness or water retention typical of aromatizing compounds.
- Pre-Contest Hardening: Dramatically enhances vascular striations, muscle separation, and overall physical density during caloric deficit phases.
- Progressive Strength Generation: Drives significant increases in kinetic power output and mechanical load capacity through strong central androgenic receptor activation.
Biomarker Health, Injection Comfort & PCT
While DHB does not aromatize or elevate prolactin, its potent androgenic and metabolic characteristics require disciplined cycle management:
- Mandatory Exogenous Testosterone Base: Dihydroboldenone suppresses endogenous gonadotropin secretion (LH and FSH). Combining DHB with an exogenous testosterone base is essential to maintain baseline estradiol and physiological function.
- Injection Comfort Considerations: Due to the high melting point and crystal structure of the DHB raw hormone, formulations can sometimes cause mild post-injection pain (PIP). Slow, deep intramuscular administration into large muscle groups helps promote comfortable absorption.
- Lipid & Cardiovascular Vigilance: Non-aromatizing anabolic compounds can depress HDL cholesterol and raise LDL fractions. Co-supplementation with omega-3 fatty acids, citrus bergamot, and consistent cardiovascular conditioning is strongly advised.
- Post Cycle Recovery (PCT): Following complete metabolic clearance of the cypionate ester (typically 12 to 14 days after the final injection), a structured SERM regimen utilizing Clomiphene or Tamoxifen must be executed to restore natural endocrine signaling.
Quality Certification & Discreet Order Fulfillment
- HPLC Lab Certified: All injectable batches undergo third-party high-performance liquid chromatography analysis to confirm exact active concentration, sterility, and total absence of heavy metals.
- Discreet Shockproof Packaging: Glass vials and ampoules are safely secured inside unbranded, impact-resistant parcels with no external indicators to maintain complete recipient privacy.
- Tracked Global Transit: Reliable dispatch accompanied by real-time end-to-end parcel tracking ensures full visibility from dispatch directly to your destination.